Becton Dickinson and Co had six patents in 3D printing during Q4 2023. Becton Dickinson and Co has developed resorbable implants made from poly(butylene succinate) and copolymers, suitable for procedures requiring prolonged strength retention and containing bioactive agents. They can be made from fibers, meshes, or 3D printing, with optional orientation. Additionally, coverings and receptacles made from these materials are designed for use with cardiac rhythm management devices and other implants, containing antibiotics like rifampin and minocycline. GlobalData’s report on Becton Dickinson and Co gives a 360-degreee view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Becton Dickinson and Co - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Becton Dickinson and Co grant share with 3D printing as a theme is 50% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Hernia repair, breast reconstruction and sling devices containing poly(BUTYLENE SUCCINATE) and copolymers thereof (Patent ID: US20230414829A1)

The patent filed by Becton Dickinson and Co. describes the development of resorbable implants made from poly(butylene succinate) and copolymers, which are sterilized and contain low levels of endotoxins. These implants are suitable for procedures requiring prolonged strength retention and can also incorporate bioactive agents. The implants can be in the form of fibers, meshes, or made using 3D printing technology. Additionally, coverings and receptacles made from poly(butylene succinate) and copolymers are designed for use with cardiac rhythm management devices and other implantable devices, containing antibiotics like rifampin and minocycline.

The patent further includes claims for specific resorbable implants such as hernia repair mesh, breast reconstruction mesh, mastopexy device, and sling device, all made from a polymeric composition containing 1,4-butanediol and succinic acid units. These implants can be formed by 3D printing and may consist of monofilament or multifilament fibers, with oriented fibers contributing to increased burst strength. The orientation of fibers can be achieved through drawing, with a higher total orientation ratio resulting in improved strength properties for the implants.

To know more about GlobalData’s detailed insights on Becton Dickinson and Co, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.